[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Kerry O'Rourke\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":43},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":12,"acronym":4,"eligibilityCriteria":13,"healthyVolunteers":10,"sex":14,"minAge":15,"maxAge":4,"enrollmentInfo":16,"targetDuration":4,"studyType":19,"phases":20,"briefSummary":22,"conditions":23,"keywords":25,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":32,"lastUpdatePostDateStruct":33,"startDateStruct":36,"completionDateStruct":38,"leadSponsor":40,"locationsCount":5},"100537946",false,"NCT06284434","Liposomal Bupivacaine Use in Alveolar Bone Graft Patients","Inclusion Criteria:\n\n* Patients that are 6 and older who have a diagnosis of cleft lip and\u002For palate with a scheduled surgery that involves an alveolar bone graft.\n\nExclusion Criteria:\n\n* Patients under age 6 are excluded from this study as EXPAREL® is not FDA approved for this group.\n* Patients with a history of allergic or adverse reaction to any drug involved in the study (EXPAREL, Epinephrine, or Bupivacaine).\n* Patients with a history of cardiovascular disease.","ALL","6 Years",{"count":17,"type":18},60,"ESTIMATED","INTERVENTIONAL",[21],"PHASE3","The goal of this clinical trial is to learn if a pain medication called liposomal bupivacaine (brand name EXPAREL®) with epinephrine will provide better pain control, increased activity, and reduced use of opioids compared with the standard treatment for patients age 6 years and older with cleft lip and palate who have had an alveolar bone graft surgery. Investigators will look at:\n\n* pain scores at hip and jaw sites\n* opioid use in amount and frequency\n* scores on activity questionnaires Researchers will compare the results of these items with those of patients who had the standard treatment of bupivacaine with epinephrine.",[24],"Cleft Lip and Palate",[26,27,28,29,30],"cleft lip","cleft palate","alveolar bone graft","pain management","liposomal bupivacaine","RECRUITING","2024-07-02",{"date":34,"type":35},"2024-07-03","ACTUAL",{"date":37,"type":35},"2024-04-24",{"date":39,"type":18},"2026-04-24",{"name":41,"class":42},"Kerry O'Rourke","OTHER",""]